Efficacy and Outcome of Remdesivir and Tocilizumab Combination Against Dexamethasone for the Treatment of Severe COVID-19: A Randomized Controlled Trial

Objective: In this study, we investigated the efficacy and safety of remdesivir and tocilizumab combination therapy against dexamethasone for the management of severe COVID-19 patients. Methods: This was a multicenter study. Cases were randomly chosen and divided into two groups using an odd–even ra...

Descripción completa

Detalles Bibliográficos
Autores principales: Mohiuddin Chowdhury, Abu Taiub Mohammed, Kamal, Aktar, Abbas, Kafil Uddin, Talukder, Shubhashis, Karim, Md Rezaul, Ali, Md. Ahsan, Nuruzzaman, Md., Li, Yarui, He, Shuixiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017992/
https://www.ncbi.nlm.nih.gov/pubmed/35450050
http://dx.doi.org/10.3389/fphar.2022.690726

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017992/
https://www.ncbi.nlm.nih.gov/pubmed/35450050
http://dx.doi.org/10.3389/fphar.2022.690726

Ejemplares similares